clinical trial · NCT06846398
A Phase 2 in Adult Subjects With Hereditary Angioedema
Shanghai Argo Biopharmaceutical Co., Ltd.·phase2·active not recruiting·n = 25
Hereditary Angioedema (HAE)BW-20805BW-20805BW-20805
brief summary
A Phase 2 in Adult Subjects with Hereditary Angioedema
started
Feb 28, 2025
primary completion
Jun 30, 2026
completion
Mar 30, 2028
last updated
Apr 17, 2026
detailed description
A Phase 2, Open-label, Multicenter Study to Assess the Efficacy and Safety of BW-20805 in Adult Subjects with Hereditary Angioedema
official title
A Phase 2, Open-label, Multicenter Study to Assess the Efficacy and Safety of BW-20805 in Adult Subjects With Hereditary Angioedema
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol